SG Americas Securities
HUMA icon

SG Americas Securities’s Humacyte HUMA Stock Holding History

SG Americas Securities’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Buy
44,608
+23,571
+112% +$21.8K ﹤0.01% 3232
2026
Q1 		$13K Sell
21,037
-13,038
-38% -$13.6K ﹤0.01% 3126
2025
Q4 		$33K Buy
34,075
+11,411
+50% +$16.2K ﹤0.01% 3411
2025
Q3 		$39K Sell
22,664
-21,315
-48% -$41.8K ﹤0.01% 3228
2025
Q2 		$92K Sell
43,979
-96
-0.2% -$184 ﹤0.01% 2655
2025
Q1 		$75K Buy
44,075
+4,932
+13% +$18.5K ﹤0.01% 3133
2024
Q4 		$198K Buy
39,143
+7,069
+22% +$35K ﹤0.01% 2164
2024
Q3 		$174K Buy
+32,074
New +$211K ﹤0.01% 2610
2024
Q1 		– Sell
-16,340
Closed -$46K – 3176
2023
Q4 		$46K Buy
16,340
+5,645
+53% +$14.5K ﹤0.01% 2934
2023
Q3 		$31K Buy
+10,695
New +$35.4K ﹤0.01% 3011
2023
Q2 		– Sell
-29,921
Closed -$92K – 2668
2023
Q1 		$92K Buy
+29,921
New +$85.1K ﹤0.01% 2938
2022
Q4 		– Sell
-10,826
Closed -$35K – 3192
2022
Q3 		$35K Buy
+10,826
New +$41.5K ﹤0.01% 3046

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SG Americas Securities's HUMA Position: Q2 2026 in Review

SG Americas Securities increased its Humacyte (HUMA) stake by 112% in Q2 2026, buying an estimated $21.8K and bringing the position to 44,608 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #3232.

SG Americas Securities first reported a position in HUMA in Q3 2022 and has held it in 12 quarters since. The position peaked at $198K in Q4 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • SG Americas Securities held 44,608 shares of Humacyte worth $35K as of Q2 2026.
  • SG Americas Securities bought 23,571 Humacyte shares in Q2 2026, an estimated $21.8K.
  • Humacyte made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3232 holding.
  • SG Americas Securities first reported a position in Humacyte in Q3 2022 and has held it in 12 quarters since.
  • SG Americas Securities's Humacyte position peaked at $198K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.